These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 175640)

  • 41. Herpes virus infection of RPE and MDCK cells: polarity of infection.
    Topp KS; Rothman AL; Lavail JH
    Exp Eye Res; 1997 Mar; 64(3):343-54. PubMed ID: 9196385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The placenta in herpes].
    Mel'nikova VF; Tsinzerling AV; Mikhaĭlova LE; Popova RD; Fradkina EP
    Arkh Patol; 1984; 46(10):51-7. PubMed ID: 6095794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The elimination of herpes simplex plaques by antibody and the emergence of resistant strains.
    Pavan PR; Ennis FA
    J Immunol; 1977 Jun; 118(6):2167-75. PubMed ID: 193992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific transfer factor protects mice against lethal challenge with herpes simplex virus.
    Viza D; Vich JM; Phillips J; Rosenfeld F; Davies DA
    Cell Immunol; 1986 Jul; 100(2):555-62. PubMed ID: 3019568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
    [No Abstract]   [Full Text] [Related]  

  • 46. Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation.
    Sekizawa T; Openshaw H; Wohlenberg C; Notkins AL
    Science; 1980 Nov; 210(4473):1026-8. PubMed ID: 6254149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):192-201. PubMed ID: 60058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A micro solid-phase radioimmunoassay for detection of herpesvirus type-specific antibody: specificity and sensitivity.
    Adler-Storthz K; Matson DO; Adam E; Dreesman GR
    J Virol Methods; 1983 Feb; 6(2):85-97. PubMed ID: 6189849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides.
    Bernstein DI; Bryson YJ; Lovett MA
    J Med Virol; 1985 Mar; 15(3):251-63. PubMed ID: 2580054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental studies on genital herpetic infection in mice.
    Nishiura H; Hayakawa K; Matsui Y; Sawada M; Nii S
    Biken J; 1980 Dec; 23(4):169-77. PubMed ID: 6266394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 53. Altered immunologic specificity of cells infected with Herpes simplex virus: recognition of human antiserum.
    Schwartz J; Elizan TS
    Z Immunitatsforsch Exp Klin Immunol; 1975 Feb; 148(4):291-8. PubMed ID: 170750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural killer cytotoxicity and antibody dependent cellular cytotoxicity in human herpes simplex virus infection.
    Hristescu S; Sahnazarov N; Muţiu A; Olinescu A
    Arch Roum Pathol Exp Microbiol; 1987; 46(4):333-46. PubMed ID: 2845886
    [No Abstract]   [Full Text] [Related]  

  • 55. Natural killer cell cytotoxicity to herpes simplex virus-1-infected cells is not altered by pregnancy.
    Eriksen NL; Gonik B; Loo LS
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):965-8. PubMed ID: 1659194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of herpes simplex virus diseases in man.
    Epstein JS; Quinnan GV
    Clin Dermatol; 1984; 2(2):133-46. PubMed ID: 6100714
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro susceptibility of newborn murine retinal cells to herpes simplex virus type 1 infection.
    Merges MJ; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1224-30. PubMed ID: 2163995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
    Clancy R; Rawls WE; Jagannath S
    J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent herpes simplex virus infection in rabbit trigeminal ganglia.
    Baringer JR; Swoveland P
    Lab Invest; 1974 Feb; 30(2):230-40. PubMed ID: 4361762
    [No Abstract]   [Full Text] [Related]  

  • 60. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ; Gallo D
    J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.